KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Current Taxes: 2012-2018

Historic Current Taxes for Emergent BioSolutions (EBS) over the last 1 years, with Dec 2018 value amounting to $4.5 million.

  • Emergent BioSolutions' Current Taxes was N/A to $4.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2018, which is N/A change from last year.
  • According to the latest figures from Q4 2018, Emergent BioSolutions' Current Taxes is $4.5 million, which was up 2,643.90% from $164,000 recorded in Q3 2018.
  • Emergent BioSolutions' Current Taxes' 5-year high stood at $4.5 million during Q4 2018, with a 5-year trough of $164,000 in Q3 2018.
  • Over the past 2 years, Emergent BioSolutions' median Current Taxes value was $2.3 million (recorded in 2017), while the average stood at $2.3 million.
  • Data for Emergent BioSolutions' Current Taxes shows a maximum YoY tumbled of 91.25% (in 2018) over the last 5 years.
  • Emergent BioSolutions' Current Taxes (Quarterly) stood at $1.9 million in 2017, then tumbled by 91.25% to $4.5 million in 2018.
  • Its Current Taxes was $4.5 million in Q4 2018, compared to $164,000 in Q3 2018 and $2.8 million in Q2 2018.